Apollomics Statistics

Total Valuation

Apollomics has a market cap or net worth of $10.75 million. The enterprise value is -$10.46 million.

Market Cap	10.75M
Enterprise Value	-10.46M

Important Dates

The next estimated earnings date is Saturday, February 15, 2025, after market close.

Earnings Date	Feb 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Apollomics has 1.10 million shares outstanding. The number of shares has decreased by -77.42% in one year.

Current Share Class	1.10M
Shares Outstanding	1.10M
Shares Change (YoY)	-77.42%
Shares Change (QoQ)	+4.36%
Owned by Insiders (%)	24.49%
Owned by Institutions (%)	2.06%
Float	579,878

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.26
Forward PS	n/a
PB Ratio	0.52
P/TBV Ratio	0.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.23.

Current Ratio	2.25
Quick Ratio	2.08
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-237.40

Financial Efficiency

Return on equity (ROE) is -149.31% and return on invested capital (ROIC) is -79.94%.

Return on Equity (ROE)	-149.31%
Return on Assets (ROA)	-62.74%
Return on Capital (ROIC)	-79.94%
Revenue Per Employee	$46,689
Profits Per Employee	-$1.27M
Employee Count	45
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.81% in the last 52 weeks. The beta is 1.07, so Apollomics's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-87.81%
50-Day Moving Average	11.25
200-Day Moving Average	25.03
Relative Strength Index (RSI)	50.39
Average Volume (20 Days)	107,375

Short Selling Information

The latest short interest is 24,254, so 2.20% of the outstanding shares have been sold short.

Short Interest	24,254
Short Previous Month	289,108
Short % of Shares Out	2.20%
Short % of Float	4.18%
Short Ratio (days to cover)	0.17

Income Statement

In the last 12 months, Apollomics had revenue of $2.10 million and -$57.11 million in losses. Loss per share was -$62.95.

Revenue	2.10M
Gross Profit	2.10M
Operating Income	-53.18M
Pretax Income	-172.59M
Net Income	-57.11M
EBITDA	-53.10M
EBIT	-53.18M
Loss Per Share	-$62.95

Full Income Statement

Balance Sheet

The company has $25.93 million in cash and $4.72 million in debt, giving a net cash position of $21.21 million or $19.23 per share.

Cash & Cash Equivalents	25.93M
Total Debt	4.72M
Net Cash	21.21M
Net Cash Per Share	$19.23
Equity (Book Value)	20.81M
Book Value Per Share	18.92
Working Capital	15.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$34.80 million and capital expenditures -$24,000, giving a free cash flow of -$34.82 million.

Operating Cash Flow	-34.80M
Capital Expenditures	-24,000
Free Cash Flow	-34.82M
FCF Per Share	-$31.58

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,531.08%
Pretax Margin	-2,718.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Apollomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	77.42%
Shareholder Yield	77.42%
Earnings Yield	-531.24%
FCF Yield	-323.91%

Analyst Forecast

The average price target for Apollomics is $425.00, which is 4,258.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$425.00
Price Target Difference	4,258.97%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 25, 2024. It was a reverse split with a ratio of 0.01:1.

Last Split Date	Nov 25, 2024
Split Type	Reverse
Split Ratio	0.01:1

Scores

Apollomics has an Altman Z-Score of -25.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.02
Piotroski F-Score	2